CannBioRx Ebt Per Ebit from 2010 to 2024

ATNFW Stock  USD 0.01  0.000012  0.15%   
CannBioRx Life Ebt Per Ebit yearly trend continues to be fairly stable with very little volatility. Ebt Per Ebit will likely drop to 1.03 in 2024. During the period from 2010 to 2024, CannBioRx Life Ebt Per Ebit regression line of quarterly data had mean square error of  0.56 and geometric mean of  1.17. View All Fundamentals
 
Ebt Per Ebit  
First Reported
2010-12-31
Previous Quarter
1.6534614
Current Value
1.03
Quarterly Volatility
1.31995857
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CannBioRx Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannBioRx Life's main balance sheet or income statement drivers, such as Interest Expense of 42.59, Selling General Administrative of 7.6 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CannBioRx financial statements analysis is a perfect complement when working with CannBioRx Life Valuation or Volatility modules.
  
Check out the analysis of CannBioRx Life Correlation against competitors.

Latest CannBioRx Life's Ebt Per Ebit Growth Pattern

Below is the plot of the Ebt Per Ebit of CannBioRx Life Sciences over the last few years. It is CannBioRx Life's Ebt Per Ebit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CannBioRx Life's overall financial position and show how it may be relating to other accounts over time.
Ebt Per Ebit10 Years Trend
Slightly volatile
   Ebt Per Ebit   
       Timeline  

CannBioRx Ebt Per Ebit Regression Statistics

Arithmetic Mean0.24
Geometric Mean1.17
Coefficient Of Variation552.65
Mean Deviation1.24
Median(0.93)
Standard Deviation1.32
Sample Variance1.74
Range3.1444
R-Value0.84
Mean Square Error0.56
R-Squared0.70
Significance0.000095
Slope0.25
Total Sum of Squares24.39

CannBioRx Ebt Per Ebit History

2024 1.03
2023 1.65
2022 2.22
2021 1.3
2020 1.93
2019 1.22
2018 1.66

About CannBioRx Life Financial Statements

CannBioRx Life investors use historical fundamental indicators, such as CannBioRx Life's Ebt Per Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CannBioRx Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebt Per Ebit 1.65  1.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.